Ethanol → 3-cyclopentyl-3-(4-(7-(4-(1-methylpiperidin-4-yl)phenyl)imidazo[1,2-c]pyrimidin-5-yl)-1H-pyrazol-1-yl)propanenitrile
Reaction equation
[CH:1]1([CH:6]([N:10]2[CH:14]=[C:13]([C:15]3[N:20]4[CH:21]=[CH:22][N:23]=[C:19]4[CH:18]=[C:17]([C:24]4[CH:29]=[CH:28][C:27](N5CCOCC5)=[CH:26][CH:25]=4)[N:16]=3)[CH:12]=[N:11]2)[CH2:7][C:8]#[N:9])[CH2:5][CH2:4][CH2:3][CH2:2]1.[CH2:36](O)[CH3:37]>>[CH:1]1([CH:6]([N:10]2[CH:14]=[C:13]([C:15]3[N:20]4[CH:21]=[CH:22][N:23]=[C:19]4[CH:18]=[C:17]([C:24]4[CH:25]=[CH:26][C:27]([CH:37]5[CH2:36][CH2:15][N:20]([CH3:21])[CH2:19][CH2:18]5)=[CH:28][CH:29]=4)[N:16]=3)[CH:12]=[N:11]2)[CH2:7][C:8]#[N:9])[CH2:5][CH2:4][CH2:3][CH2:2]1Participants
3
Procedure
3-Cyclopentyl-3-(4-(7-(4-morpholinophenyl)imidazo[1,2-c]pyrimidin-5-yl)-1H-pyrazol-1-yl)propanenitrile (Example 113; 0.015 g, 0.032 mmol) was separated by chiral HPLC (Chiral Tech. OD-H, 2.2 cm×250 mm; 220 nm, 21 mL/min; 50% Ethanol: 50% Hexanes). Peak 2 was isolated to afford the single Enantiomer 2 of 3-cyclopentyl-3-(4-(7-(4-(1-methylpiperidin-4-yl)phenyl)imidazo[1,2-c]pyrimidin-5-yl)-1H-pyrazol-1-yl)propanenitrile (5.0 mg, 33% yield). MS (apci) m/z=468.2 (M+H).
Workup
- customPeak 2 was isolated
Sources & evidence
- ORD record
- ord-7557f42711dc41f89a7a27fd6ec3c6a3
- Source dataset
- uspto-grants-2015_02
- Patent number
- US08962596B2
Reaction notes
Loading…